TEVA
Teva- Pharmaceutical Industries Ltd. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$28.57
-0.73 ▼ -2.49%
🌙 3월 13일 8:00 PM ET (한국 3/14 09:00)
$28.49
-0.08 ▼ -0.28%
| Index | - | P/E | 23.47 | EPS (ttm) | 1.22 | Insider Own | 0.02% | Shs Outstand | 1.16B | Perf Week | -7.99% |
| Market Cap | 33.27B | Forward P/E | 9.23 | EPS next Y | 14.51% | Insider Trans | -91.2% | Shs Float | 1.16B | Perf Month | -16.73% |
| Enterprise Value | 46.91B | PEG | 1.67 | EPS next Q | 0.55 | Inst Own | 60.32% | Short Float | 2.79% | Perf Quarter | -4.13% |
| Income | 1.42B | P/S | 1.91 | EPS this Y | -7.7% | Inst Trans | 0.86% | Short Ratio | 3.53 | Perf Half Y | 43.64% |
| Sales | 17.39B | P/B | 4.15 | EPS next 5Y | 5.53% | ROA | 3.54% | Short Interest | 32.53M | Perf YTD | -8.46% |
| Book/sh | 6.88 | P/C | 9.36 | EPS past 3/5Y | - | ROE | 21.37% | 52W High | -23.5% ($37.35) | Perf Year | 73.57% |
| Cash/sh | 3.05 | P/FCF | 33.14 | Sales past 3/5Y | 5.53% 0.8% | ROIC | 6.12% | 52W Low | 129.2% ($12.47) | Perf 3Y | 219.57% |
| Dividend Est. | - | EV/EBITDA | 9.38 | EPS Y/Y TTM | 185.44% | Gross Margin | 51.82% | Volatility(W/M) | 3.75% 3.07% | Perf 5Y | 164.78% |
| Dividend TTM | - | EV/Sales | 2.7 | Sales Y/Y TTM | 4.73% | Oper. Margin | 22.96% | ATR (14) | 1.1 | Perf 10Y | -51.54% |
| Dividend Ex-Date | 2017/11/27 | Quick Ratio | 0.8 | EPS Q/Q | 313.26% | Profit Margin | 8.16% | RSI (14) | 23.76 | Recom | 1.36 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.04 | Sales Q/Q | 12.42% | SMA20 | -12.53% ($32.66) | Beta | 0.76 | Target Price | $39.78 |
| Payout | - | Debt/Eq | 2.17 | Earnings | 1000000 | SMA50 | -13% ($32.84) | Rel Volume | 0.84 | Prev Close | $29.3 |
| Employees | 33346 | LT Debt/Eq | 1.93 | EPS/Sales Surpr. | 49.7% 9.13% | SMA200 | 21.36% ($23.54) | Avg Volume(3M) | 9.20M | Price | $28.57 |
| IPO | 1982/2/16 | Option/Short | Yes/Yes | Trades | 32502 | Volume | 7,773,810 | Change | -2.49% |
뉴스 로딩 중...